Literature DB >> 14509465

Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.

Vinicius S Saraiva1, Juliana M F Sallum, Michel E Farah.   

Abstract

A case of cystoid macular edema related to retinitis pigmentosa treated with intravitreal injection of triamcinolone acetonide is described. A 30-year-old white man with retinitis pigmentosa and progressive visual loss presented with a best-corrected visual acuity of 20/40 in the right eye and 20/80 in the left eye. Examination revealed cystoid macular edema in both eyes. After failure of treatment with oral acetazolamide, intravitreal injection of 0.1 mL of triamcinolone acetonide 0.4% solution was performed in both eyes. In the left eye, macular edema resorbed and visual acuity improved to 20/50. However, 6 months after injection, visual acuity worsened because of recurrence of cystoid macular edema. In the right eye, cystoid macular edema also resorbed, but visual acuity was unchanged. Intravitreal triamcinolone acetonide may be useful for selected cases of cystoid macular edema related to retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14509465

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  14 in total

1.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

2.  Cystoid macular edema related to diabetic retinopathy with retinitis pigmentosa.

Authors:  Kazuki Hotta; Junko Hotta
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

3.  Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors:  B R Kosobucki; W R Freeman; L Cheng
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

4.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

5.  Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa.

Authors:  Mayer Srour; Giuseppe Querques; Nicolas Leveziel; Jennyfer Zerbib; Julien Tilleul; Elise Boulanger-Scemama; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-29       Impact factor: 3.117

6.  Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2007-12-22       Impact factor: 2.031

Review 7.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

8.  Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa.

Authors:  Mikiko Takezawa; Soichi Tetsuka; Akihiro Kakehashi
Journal:  Clin Ophthalmol       Date:  2011-02-21

9.  Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.

Authors:  Francesco Parmeggiani; Giovanni Sato; Katia De Nadai; Mario R Romano; Andrea Binotto; Ciro Costagliola
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

10.  Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema.

Authors:  Ali Osman Saatci; Ozlem Barut Selver; Goktug Seymenoglu; Aylin Yaman
Journal:  Case Rep Ophthalmol       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.